Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALPG | P10696 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6009336 | 0.80 | ALDH1A1 (0.50) | ALDH1A1POLBKMT2AMEN1RECQL | |
| Bromide SCHEMBL6009283 | 0.75 | POLB (0.45) | ALDH1A1POLBKMT2AMEN1RECQL | |
| Bromide SCHEMBL6009264 | 0.75 | ALDH1A1 (0.49) | ALDH1A1POLBKMT2AMEN1RECQL | |
| Hydrochloric Acid SCHEMBL7421854 | 0.71 | ALDH1A1 (0.49) | ALDH1A1POLBKMT2AMEN1RECQL | |
| Hydrochloric Acid SCHEMBL3844254 | 0.71 | ALDH1A1 (0.46) | ALDH1A1POLBKMT2AMEN1RECQL | |
| Bromide SCHEMBL6074531 | 0.71 | ALDH1A1 (0.55) | ALDH1A1POLBKMT2AMEN1RECQL | |
| SCHEMBL23752059 | 0.69 | ALDH1A1 (0.53) | ALDH1A1POLBKMT2AMEN1RECQL | |
| SCHEMBL18745980 | 0.69 | RAB9A (0.55) | ALDH1A1POLBKMT2AMEN1RECQL | |
| Hydrochloric Acid SCHEMBL3845958 | 0.68 | RAB9A (0.54) | ALDH1A1POLBKMT2AMEN1RECQL | |
| Bromide SCHEMBL6009338 | 0.68 | KMT2A (0.51) | ALDH1A1POLBKMT2AMEN1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090088461-A1 | Methods of Treating or Preventing Cardiac Disease Associated With a High Fat Diet | SYNVISTA THERAPEUTICS, INC. (US) | 2009-04-02 | — | — | US | disclosed |
| US-20070025926-A1 | Preventing and reversing the formation of advance glycosylation endproducts | SYNVISTA THERAPEUTICS, INC. | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088461-A1 | Methods of Treating or Preventing Cardiac Disease Associated With a High Fat Diet | FABP3, TXNRD2, PPARD | ALDH1A1 653/4885POLB 3920/4885KMT2A 3186/4885 |
| US-20070025926-A1 | Preventing and reversing the formation of advance glycosylation endproducts | AGER, PTMS, OGA | ALDH1A1 1227/4885POLB 2423/4885KMT2A 3689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.